Daniel Shirley, MD, MS, is assistant professor in the division of infectious disease at the University of Wisconsin–Madison School of Medicine and Public Health and the William S. Middleton Memorial Veterans Hospital. Nasia Safdar, MD, PhD, is associate professor in the division of infectious disease at the University of Wisconsin–Madison School of Medicine and Public Health and the William S. Middleton Memorial Veterans Hospital.
Related Articles
Prophylactic anticoagulation tied to lower death rate in COVID
December 15, 2016
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.
![1]()
Update in Hospital Medicine relays important findings
December 15, 2016
Two panelists highlighted the year of research in areas most relevant and important to hospital medicine.
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
December 15, 2016
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation, but best dosing remains unclear, researchers say.
![1]()
COVID-19 and risk of clotting: ‘Be proactive about prevention’
December 15, 2016
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of thromboprophylaxis," authors of a review article say.
